CRISPR-Q Trademark

Trademark Overview


On Friday, June 18, 2021, a trademark application was filed for CRISPR-Q with the United States Patent and Trademark Office. The USPTO has given the CRISPR-Q trademark a serial number of 79326535. The federal status of this trademark filing is REGISTERED as of Tuesday, September 27, 2022. This trademark is owned by Qiagen GmbH. The CRISPR-Q trademark is filed in the Chemical Products and Pharmaceutical Products categories with the following description:

Diagnostic preparations for medical and veterinary purposes, namely, diagnostic preparations for marking, separating, isolating, amplifying, cloning, sequencing and/or for the analysis of biopolymers in the nature of acids; diagnostic reagents, enzymes and buffer solutions for isolating, amplifying and analysing nucleic acids for medical or veterinary purposes; chemical, biochemical and biotechnological diagnostic preparations for medical and veterinary purposes, namely, reagents, enzymes and buffer solutions for marking, separating, isolating, amplifying, cloning, sequencing and/or for the analysis of biopolymers in the nature of nucleic acids; diagnostic kits containing preparations for medical and veterinary diagnostic purposes, namely, preparations for marking, separating, isolating, amplifying, cloning, sequencing and/or for the analysis of biopolymers in the nature of nucleic acids; diagnostic kits containing reagents, enzymes and buffer solutions for isolating, amplifying and an...

Chemical, biochemical and biotechnological diagnostic preparations for scientific use; non-medical reagents used in analytical chemistry, for scientific and/or medical research use for marking, separating, isolating, amplifying, cloning, sequencing and/or for the analysis of biopolymers in the nature of nucleic acids, in particular reagents, enzymes and buffer solutions for isolating, amplifying and analysing nucleic acids; chemical test kits for laboratory or research use for marking, separating, isolating, amplifying, cloning, sequencing and/or for the analysis of biopolymers in the nature of nucleic acids, in particular comprising reagents, enzymes and buffer solutions for isolating, amplifying and analysing nucleic acids
crispr-q

General Information


Serial Number79326535
Word MarkCRISPR-Q
Filing DateFriday, June 18, 2021
Status700 - REGISTERED
Status DateTuesday, September 27, 2022
Registration Number6854769
Registration DateTuesday, September 27, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 12, 2022

Trademark Statements


Goods and ServicesDiagnostic preparations for medical and veterinary purposes, namely, diagnostic preparations for marking, separating, isolating, amplifying, cloning, sequencing and/or for the analysis of biopolymers in the nature of acids; diagnostic reagents, enzymes and buffer solutions for isolating, amplifying and analysing nucleic acids for medical or veterinary purposes; chemical, biochemical and biotechnological diagnostic preparations for medical and veterinary purposes, namely, reagents, enzymes and buffer solutions for marking, separating, isolating, amplifying, cloning, sequencing and/or for the analysis of biopolymers in the nature of nucleic acids; diagnostic kits containing preparations for medical and veterinary diagnostic purposes, namely, preparations for marking, separating, isolating, amplifying, cloning, sequencing and/or for the analysis of biopolymers in the nature of nucleic acids; diagnostic kits containing reagents, enzymes and buffer solutions for isolating, amplifying and analysing nucleic acids for medical or veterinary purposes
Goods and ServicesChemical, biochemical and biotechnological diagnostic preparations for scientific use; non-medical reagents used in analytical chemistry, for scientific and/or medical research use for marking, separating, isolating, amplifying, cloning, sequencing and/or for the analysis of biopolymers in the nature of nucleic acids, in particular reagents, enzymes and buffer solutions for isolating, amplifying and analysing nucleic acids; chemical test kits for laboratory or research use for marking, separating, isolating, amplifying, cloning, sequencing and/or for the analysis of biopolymers in the nature of nucleic acids, in particular comprising reagents, enzymes and buffer solutions for isolating, amplifying and analysing nucleic acids

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateMonday, November 29, 2021
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, November 29, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameQiagen GmbH
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressDE

Party NameQiagen GmbH
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDE

Party NameQiagen GmbH
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDE

Trademark Events


Event DateEvent Description
Wednesday, January 25, 2023FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, January 25, 2023FINAL DISPOSITION PROCESSED
Tuesday, December 27, 2022FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, September 27, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, September 27, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, July 19, 2022NOTIFICATION PROCESSED BY IB
Tuesday, July 12, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 12, 2022PUBLISHED FOR OPPOSITION
Wednesday, June 29, 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, June 29, 2022NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, June 22, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, June 9, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, May 16, 2022REFUSAL PROCESSED BY IB
Thursday, May 12, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, May 12, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 12, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, April 26, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, April 26, 2022REFUSAL PROCESSED BY MPU
Wednesday, March 16, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, March 15, 2022NON-FINAL ACTION WRITTEN
Thursday, March 10, 2022ASSIGNED TO EXAMINER
Friday, December 3, 2021APPLICATION FILING RECEIPT MAILED
Monday, November 29, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, November 25, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB